CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM NEW
Total 13F shares
356,966
Share change
+324,580
Total reported value
$11,230,000
Price per share
$31.46
Number of holders
21
Value change
+$10,430,802
Number of buys
20
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q1 2015

As of 31 Mar 2015, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 356,966 shares. The largest 10 holders included FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., DRIEHAUS CAPITAL MANAGEMENT LLC, EAM Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CREDIT SUISSE AG/, UBS Group AG, PANAGORA ASSET MANAGEMENT INC, Wexford Capital LP, and NORTHERN TRUST CORP. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.